Ocuphire Pharma Inc. buy Cantor Fitzgerald
Start price
14.08.23
/
50%
€3.83
Target price
14.08.24
€15.55
Performance (%)
-72.32%
End price
15.08.24
€1.06
Summary
This prediction ended on 15.08.24 with a price of €1.06. Massive losses of -72.32% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocuphire Pharma Inc. | -10.754% | -10.754% | 89.855% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $17.00 price target on the stock.
Ratings data for OCUP provided by MarketBeat
In the thread Trading Ocuphire Pharma Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten